North America Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)
Market Introduction
The North America virology market is analyzed based on three major countries: the US, Canada, and Mexico. The US holds the largest size of the virology market owing to factors such as the increasing burden of COVID19, increasing product launches are among the factors leading the market. In North America, the US is the largest market for virology solutions. The growth of the US market is primarily driven by increasing research and development activities and rising demand for advanced diagnostic solutions to treat chronic conditions and viral diseases. In addition, increasing demand for viral antigens due to the growing adoption of advances viral testing is also anticipated to drive the market during the forecast period. Due to the increasing demand, major players in the market are focusing on expanding their viral antigens manufacturing capacity. The pharmaceutical and biotechnology companies in the country are actively operating to develop effective vaccines for COVID19. Various players have received EUA for respective vaccines. The data is being studied continuously on a larger scale, and the drug manufacturers are consistently developing antiviral drugs for COVID19. However, despite the commercialization and widespread access to vaccines, the primary focus is still to perform maximum testing for COVID19 to control the infection rate. For instance, in May 2020, the US FDA approved emergency use authorization for a COVID19 antigen test from Quidel Corporation for the Sofia 2 SARS Antigen FIA. Thus, similar approvals by the regulatory agencies are expected to support the growth of the virology market. Rise in prevalence of viral infectious diseases is the major factor driving the growth of the North America virology market.
North America has experienced a rising number of cases of COVID-19 since its outbreak. The cases are also increasing in countries such as Mexico and Canada in the region. As COVID19 is a novel virus and had no established treatment methods, no vaccines, drugs specific to the virus were not available. Thus, it was a potential opportunity for product innovation and development to the market players operating in the virology-related business. The governments have extensively invested in and promoted vaccine development and prioritized the easy and quick approval process. Regional and international players launch various virus products such as rapid test kits, vaccines, and others. And the large-scale production of these products and rising demand are expected to have a favorable impact on the virology-related market in the region. However, the end-users' panic buying and stocking of the products are expected to cause a loss in terms of product expiry. Thus, such factors are expected to have a negative impact on the related market in the region.
Get more information on this report :
Market Overview and Dynamics
The virology market in North America is expected to grow from US$ 1,531.21 million in 2021 to US$ 1,984.33 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028. Countries such as Mexico are attractive outsourcing locations for the pharmaceutical and biopharmaceutical industries across the region. Low manufacturing and operating costs and recent growth in the pharmaceutical industry in Mexico are key factors driving the growth of the virology-related markets in this country. Moreover, the growing domestic market and its pipelines are opening new access for the manufacturing of generic drugs in the region. In addition, several contract-based organizations are expanding their manufacturing capacities in North American nations to meet the rising demand for products, such as vaccines. Thus, the emerging markets are likely to create lucrative opportunities for the growth of the virology market in the coming years across the North America region.
Key Market Segments
The North America virology market is segmented on the bases of type, application, end user, and country. Based on type, the market is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. The antiviral therapeutics segment dominated the market in 2020 and viral infection controlling techniques segment is expected to be the fastest growing during the forecast period. The diagnostic test segment is further categorized into DNA virus testing, RNA virus testing, others. Similarly, the viral infection controlling techniques is bifurcated into active prophylaxis, and passive prophylaxis. Likewise, the antiviral therapeutics segment is categorized into virucidal agents, antiviral agents, immunomodulators, and interferons. On the basis of application, the virology market is segmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infections, and others. The respiratory tract infections segment dominated the market in 2020, and is expected to be the fastest growing during the forecast period. On the basis of end user, the virology market is segmented into hospitals, diagnostic laboratories, pharmaceutical and biotechnological companies, and research and academic institutes. The hospitals segment dominated the market in 2020, and diagnostic laboratories segment is expected to be the fastest growing during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the virology market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; AbbVie Inc.; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline Plc; Illumina, Inc.; Johnson and Johnson Services, Inc.; QIAGEN; Siemens AG; and Thermo Fisher Scientific Inc. are among others.
Reasons to buy report
- To understand the North America virology market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America virology market
- Efficiently plan M&A and partnership deals in North America virology market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America virology market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Virology Market Segmentation
North America Virology Market -By Type
- Diagnostic Test
- DNA Virus Testing
- RNA Virus Testing
- Others
- Viral Infection Controlling Techniques
- Active Prophylaxis
- Passive Prophylaxis
- Antiviral Therapeutics
- Virucidal Agents
- Antiviral Agents
- Immunomodulators
- Interferons
North America Virology Market -By Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Others
North America Virology Market -By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
North America Virology Market -By Country
- US
- Canada
- Mexico
North America Virology Market -Company Profiles
- Abbott
- AbbVie Inc.
- . F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Virology Market – By Type
1.3.2 North America Virology Market – By Application
1.3.3 North America Virology Market – By End User
1.3.4 North America Virology Market– By Country
2. North America Virology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Virology Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Virology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Viral Infectious Diseases
5.1.2 Increasing Product Launches
5.2 Market Restraints
5.2.1 Availability of Alternative Products and High Cost of Production of Products
5.3 Market Opportunities
5.3.1 Tremendous Growth Potential in Several Economies
5.4 Future Trends
5.4.1 Continuous Requirement for Cost-Effective Products
5.5 Impact Analysis
6. Virology Market– North America Analysis
6.1 North America Virology Market Revenue Forecast and Analysis
7. North America Virology Market Analysis – By Type
7.1 Overview
7.2 North America Virology Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Test
7.3.1 Overview
7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1 Overview
7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1 Overview
7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Others
7.3.2.3.1 Overview
7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Infection Controlling Techniques
7.4.1 Overview
7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Active Prophylaxis
7.4.2.1.1 Overview
7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Passive Prophylaxis
7.4.2.2.1 Overview
7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Antiviral Therapeutics
7.5.1 Overview
7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Virucidal Agents
7.5.2.1.1 Overview
7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Antiviral Agents
7.5.2.2.1 Overview
7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Immunomodulators
7.5.2.3.1 Overview
7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Interferons
7.6.1 Overview
7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Virology Market Analysis – By Application
8.1 Overview
8.2 North America Virology Market, by Application 2021 & 2028 (%)
8.3 Skin and Soft Tissue Infections
8.3.1 Overview
8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Tract Infections
8.4.1 Overview
8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 GI Tract Infections
8.5.1 Overview
8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sexually Transmitted Diseases
8.6.1 Overview
8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Virology Market Analysis – By End User
9.1 Overview
9.2 North America Virology Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pharmaceutical and Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Research and Academic Institutes
9.6.1 Overview
9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Virology Market – Country Analysis
10.1.1 Overview
10.1.2 North America: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Virology Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.1.3.1 US: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.3.2 US: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.3.3 US: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.4 US: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.2.3.1 Canada: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.3.2 Canada: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.3.3 Canada: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.3.3.1 Mexico: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.3.2 Mexico: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.3.3 Mexico: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Virology Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Virology Market
11.1 Overview
12. North America Virology Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Johnson and Johnson Services, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QIAGEN
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Illumina, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AbbVie Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. US Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, North America Virology Market
LIST OF FIGURES
Figure 1. North America Virology Market Segmentation
Figure 2. North America Virology Segmentation, By Country
Figure 3. North America Virology Market Overview
Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in North America Virology Market
Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in North America Virology Market
Figure 6. US to Show Significant Growth During Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Virology Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11. North America Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Virology Market, by Application 2021 & 2028 (%)
Figure 24. North America Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31. North America Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. North America: Virology Market, by Country, 2021 & 2028 (%)
Figure 37. US: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Virology market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Virology market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution